Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer

Author: Caponigro F.   Dittrich C.   Sorensen J.B.   Schellens J.H.M.   Duffaud F.   Paz Ares L.   Lacombe D.   de Balincourt C.   Fumoleau P.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.1, 2002-01, pp. : 70-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content